Peruvoside
From Infogalactic: the planetary knowledge core
File:Peruvoside.svg | |
Systematic (IUPAC) name | |
---|---|
(3β,5β,8ξ,9ξ)- 3-[(6-deoxy- 3-O-methyl- α-D- glycero- hexopyranosyl)oxy]- 14-hydroxy- 19-oxocard- 20(22)enolide
|
|
Identifiers | |
CAS Number | 1182-87-2 |
ATC code | C01AX02 (WHO) |
PubChem | CID: 14449 |
ChemSpider | 16498835 |
ChEMBL | CHEMBL1075790 |
Synonyms | (3S,5R,10R,13R,14S,17R)- 3-[(2S,5R)- 3,5-dihydroxy- 4-methoxy- 6-methyloxan- 2-yl]oxy- 14-hydroxy- 13-methyl- 17-(5-oxo-2H-furan-3-yl)- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthrene- 10-carbaldehyde |
Chemical data | |
Formula | C30H44O9 |
Molecular mass | 548.665 g/mol |
|
|
|
|
(what is this?) (verify) |
Peruvoside (or cannogenin thevetoside) is a cardiac glycoside[1] for heart failure.[2]
It is derived from Cascabela thevetia (Thevetia neriifolia).[2]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs with no legal status
- Cardenolides
- Alcohols
- Aldehydes
- Cardiovascular system drug stubs